Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 1/20 | 0.55 |
| ▸ | NOS1 | P29475 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | NOS3 | P29474 | 2/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3282776 | 0.80 | MEN1 (0.61) | PLAUNOS1ALDH1A1HSD17B10ACHE | |
| SCHEMBL3282773 | 0.80 | MEN1 (0.61) | PLAUNOS1ALDH1A1HSD17B10ACHE | |
| SCHEMBL3173958 | 0.80 | PLAU (0.59) | PLAUNOS1ALDH1A1HSD17B10ACHE | |
| SCHEMBL27909482 | 0.79 | ALDH1A1 (0.72) | ALDH1A1HSD17B10ACHELMNACES1 | |
| SCHEMBL22567 | 0.79 | ALDH1A1 (0.72) | ALDH1A1HSD17B10ACHELMNACES1 | |
| SCHEMBL4365351 | 0.78 | PLAU (0.57) | PLAUNOS1ALDH1A1HSD17B10ACHE | |
| SCHEMBL5501400 | 0.77 | PLAU (0.52) | PLAUNOS1ALDH1A1HSD17B10ACHE | |
| Cyanide SCHEMBL27760347 | 0.76 | ALDH1A1 (0.62) | ALDH1A1HSD17B10ACHELMNACES1 | |
| SCHEMBL4168380 | 0.76 | NOS1 (0.59) | PLAUNOS1ALDH1A1HSD17B10ACHE | |
| SCHEMBL12155535 | 0.76 | PLAU (0.55) | PLAUNOS1ALDH1A1HSD17B10ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220404323-A1 | INDICATOR MATERIAL COMPRISING A POLYMERIC GEL CARRIER AND POLYMERIC INDICATOR | MOOW.FARM KFT. (HU) | 2022-12-22 | — | — | US | claimed |
| CN-110372534-A | A kind of 4- nitrophenylazo vanillic aldehyde and its preparation method and application | 莆田学院 | 2019-10-25 | — | — | CN | claimed |
| CN-109824607-A | A kind of preparation method of bis-azo compound diazo component | 上海应用技术大学 | 2019-05-31 | — | — | CN | claimed |
| CN-106459812-A | Method for lubricating an internal combustion engine | 路博润公司 | 2017-02-22 | — | — | CN | claimed |
| US-8476390-B2 | Light filters comprising P-nitrophenylazo salicylic acid derivatives thereof | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2013-07-02 | — | — | US | claimed |
| US-8119778-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2012-02-21 | — | — | US | claimed |
| EP-2032370-B1 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | BASF SE (DE) | 2010-11-10 | — | — | EP | claimed |
| US-20100256306-A1 | LIGHT FILTERS COMPRISING P-NITROPHENYLAZO SALICYLIC ACID DERIVATIVES THEREOF | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2010-10-07 | — | — | US | claimed |
| US-20100234494-A1 | Reversibly thermochromic compositions | CIBA CORPORATION | 2010-09-16 | — | — | US | claimed |
| EP-2201946-A1 | PAI-1 PRODUCTION INHIBITOR | Institute of Medicinal Molecular Design, Inc. (JP) | 2010-06-30 | — | — | EP | claimed |
| US-5011924-A | Measurement Of Ions | TECHNICON INSTRUMENTS CORPORATION (US) | 1991-04-30 | — | — | US | claimed |
| US-4994395-A | Determination of potassium cations | TECHNICON INSTRUMENTS CORPORATION (US) | 1991-02-19 | — | — | US | claimed |
| US-4992381-A | Method of detecting electrolytes in an aqueous test sample using chromogenic hemispherands and test device therefor | TECHNICON INSTRUMENTS CORPORATION (US) | 1991-02-12 | — | — | US | claimed |
| US-4859606-A | Method for detecting cations in a test sample utilizing chromogenic cryptahemispherands | TECHNICON INSTRUMENTS CORPORATION (US) | 1989-08-22 | — | — | US | claimed |
| US-4808539-A | CRYPT COMPOUNDS | TECHNICON INSTRUMENTS CORPORATION (US) | 1989-02-28 | — | — | US | claimed |
| EP-0287330-A2 | Chromogenic hemispherands useful for detecting electrolytes | Bayer Corporation (US) | 1988-10-19 | — | — | EP | claimed |
| EP-0287327-A2 | Compounds for determining cations | Bayer Corporation (US) | 1988-10-19 | — | — | EP | claimed |
| EP-0287329-A2 | Chromogenic cryptahemispherands useful in detecting electrolytes | Bayer Corporation (US) | 1988-10-19 | — | — | EP | claimed |
| US-4113720-A | Disperse azo dye with diaminopyrimidine coupling component | BASF AKTIENGESELLSCHAFT (DE) | 1978-09-12 | — | — | US | claimed |
| US-4011208-A | 3-CYANO OR ACYL-4-ARYL-5-ARYLAZO-6-HYDROXYPYRIDONE-2 DYES | SANDOZ LTD. (CH) | 1977-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234494-A1 | Reversibly thermochromic compositions | CRY1, REL, CRY2 | PLAU 4821/4885NOS1 194/4885ALDH1A1 3798/4885 |
| US-20100256306-A1 | LIGHT FILTERS COMPRISING P-NITROPHENYLAZO SALICYLIC ACID DERIVATIVES THEREOF | UACA, SUN2, VHL | PLAU 2187/4885NOS1 2239/4885ALDH1A1 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.